Tag: wellness

Categories
All Family Health Anti Cancer Cancer Treatment Cancer Treatment & Outcomes Cancer Treatment Guidance Cancer Treatment Options Cancer Wellness Protocols Drug Repurposing & Innovation Fenbendazole Fenbendazole and Cancer Health & Wellness integrative-oncology Ivermectin Mebendazole Non-Chemo Cancer Treatments Pillar Repurposed Drugs and Cancer Research

CAC Announces New Relationship with All Family Health

Courage Against cancer and All Family Health partner for better outcomes

Courage Against Cancer is excited to announce a new relationship with All Family Health, expanding access to convenient telehealth consultations with licensed healthcare providers. Through this new resource, individuals can request medical evaluations for prescription medications including ivermectin and mebendazole, when clinically appropriate. CAC does not prescribe or determine treatment—we connect our community with additional healthcare resources so patients can have informed conversations with qualified medical professionals about their options.

Categories
Biome Health Cancer Support & Encouragement Cancer Treatment Options Cancer Wellness Protocols Faith & Inspiration Genetic Testing Genome Sequencing Gut Biome Gut-Microiome Health & Wellness Non-Chemo Cancer Treatments nutrition Wellness Blueprint

New Video: How CAC Wellness Blueprint Turns Your Test Results Into a Real Plan

Coco the Koala presenting CAC Wellness Blueprint

A short video walking through how CAC Wellness Blueprint works — from your test kit to your results call to ongoing coaching — grounded in CAC’s own research and current national studies on genomics and the microbiome.

Categories
Anti Cancer Breakthrough Therapies Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Outcomes Cancer Treatment Guidance Cancer Treratments Drug Repurposing & Innovation Fenbendazole Integrative Oncology Insights Ivermectin Mebendazole Non-Chemo Cancer Treatments Repurposed Drug Studies

Fenbendazole Dosage Guide for Humans 2026

Fenbendazole dosage guide for humans - featured image

Fenbendazole is one of the most talked-about topics in cancer communities heading into 2026 — and we’re adding our voice to the conversation. Watch our latest video where we share our take on FBZ, then grab our free downloadable dosage guideline to keep on hand.

Categories
Anti Cancer Breakthrough Therapies Cancer Research & Clinical Evidence Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Research & Critical Analysis Cancer Treratments Cancer Wellness Protocols Colorectal Cancer Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Hulscher Study Integrative Oncology Insights Ivermectin Mebendazole Natural Treatments Non-Chemo Cancer Treatments Pancreatic Cancer Repurposed Drug Studies Research News & Updates Wellness Company

The Anticancer Research Expression of Concern: Data Verifiability, Statistical Reliability, and Ethical Oversight Questions Selling the Product Studied? The Wellness Company’s Commercial Role Explained

The article discusses an Expression of Concern issued by Anticancer Research regarding the Hulscher et al. study on ivermectin and mebendazole. It highlights data verifiability issues, the authors’ conflicts of interest tied to The Wellness Company, and how this study differs from credible cancer research, ultimately urging caution for patients evaluating such claims.

Categories
Anti Cancer Cancer Research & Clinical Evidence Cancer Support & Encouragement Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treatment Claims & Critical Analysis Cancer Treatment Options Cancer Treatment Research & Critical Analysis Cancer Wellness Protocols Colorectal Cancer Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Hulscher Study Integrative Oncology Insights Ivermectin Mebendazole Natural Treatments Non-Chemo Cancer Treatments Pancreatic Cancer Repurposed Drug Studies Research News & Updates

What Oncologists and Evidence-Based Medicine Say About Ivermectin for Cancer Right Now

What science says about iveremctin and cancer

Courage Against Cancer clarifies that ivermectin lacks validated clinical evidence as a cancer treatment despite preclinical interest. Major oncology institutions do not endorse it, emphasizing the importance of rigorous evidence-based evaluations. Patients are encouraged to discuss concerns with their oncologists and critically assess claims surrounding off-label treatments.

Categories
Anti Cancer Cancer Research Literacy Cancer Support & Encouragement Cancer Treatment Cancer Treatment Guidance Cancer Treatment Options Colorectal Cancer Critical Evaluation of Cancer Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Integrative Oncology Insights Ivermectin Joe Tippins Mebendazole Natural Treatments Non-Chemo Cancer Treatments Repurposed Drug Studies

The Joe Tippens Story: How a Veterinary Dewormer Became a Viral Cancer Cure Claim

Is ivermectin safe treatment for cancer

The article from Courage Against Cancer discusses Joe Tippens, whose recovery from small cell lung cancer was linked to fenbendazole, a veterinary dewormer. It emphasizes that his case lacks clinical validation and critical context, such as concurrent immunotherapy, highlighting the importance of distinguishing personal narratives from scientific evidence in cancer treatment discussions.

Categories
Anti Cancer Cancer Research & Clinical Evidence Cancer Support & Encouragement Cancer Treatment & Clinical Research Cancer Treatment Research & Critical Analysis Cancer Wellness Protocols Drug Repurposing & Innovation Health & Wellness Hulscher Study Ivermectin Mebendazole Non-Chemo Cancer Treatments Repurposed Drug Studies Wellness Company

Breaking Down the Study Design: Why Observational and Self-Reported Data Have Serious Limits

Why Observational Self Reported data have serious limits

Courage Against Cancer critiques the methodology of the Hulscher et al. study on cancer treatment, emphasizing the weaknesses of observational design and self-reported outcomes. It highlights issues like lack of randomization, potential bias, and conflicts of interest, stressing that results cannot reliably inform clinical decisions and urging patients to consult oncologists about research before acting.

Categories
Anti Cancer cancer research Cancer Support & Encouragement Cancer Treatment & Clinical Research Cancer Treatment & Outcomes Cancer Treratments Cancer Wellness Protocols Community Impact Critical Evaluation of Cancer Research Drug Repurposing & Innovation Evaluating Cancer Treatment Claims Fenbendazole Health & Wellness Hulscher Study Integrative Oncology Insights Ivermectin Mebendazole Non-Chemo Cancer Treatments preclinical trial Research & Science

Why did Anticancer Research publish an expression of concern about the 2026 ivermectin study on June 1, 2026?

On June 1, 2026, Anticancer Research issued an Expression of Concern regarding Hulscher et al.’s study on ivermectin-mebendazole, citing issues with data verifiability, statistical reliability, and ethical oversight. The study’s self-reported outcomes and lack of independent monitoring raised further doubts, necessitating independent scrutiny before clinical application.

Categories
Anti Cancer Cancer Support & Encouragement Cancer Treatment Cancer Treatment & Outcomes Cancer Treatment Guidance Cancer Treatment Options Cancer Treratments FAQ Health & Wellness immunotherapy Non-Chemo Cancer Treatments

What are the main side effects of cancer treatments?

Table of Contents Direct Answer Extended Answer Related Questions Courage Against Cancer Resources Direct Answer Cancer treatments like chemotherapy, radiation, and immunotherapy can cause various side effects ranging from mild to severe. Common effects include fatigue, nausea, hair loss, and infection risk. Side effects vary greatly depending on treatment type, dosage, and individual factors. Your […]

Categories
Anti Cancer Biome Health cancer research Cancer Support & Encouragement Cancer Treratments Cancer Wellness Protocols Genetic Testing Genome Sequencing Gut Biome immunotherapy Integrative Oncology Insights Non-Chemo Cancer Treatments

Which Cancer Types Show the Most Promise from Integrated Genomic-Microbiome Approaches?

Which Cancer Types Show the Most Promise from Integrated Genomic-Microbiome Approaches? — article featured image

Courage Against Cancer emphasizes the integration of genomic sequencing and microbiome testing to enhance cancer treatment strategies. Research indicates that the tumor microenvironment, influenced by gut microbiota, plays a crucial role in cancer behavior and treatment response, particularly in colorectal, breast, and lung cancers, advocating for personalized recovery plans.